A superbug that does not respond to the very last ditch antibiotics and that has been circulating in Asia and Europe arrives ...

Wharton's Peter Cappelli shares eye-opening research on the impact of AI on a company's productivity and headcount.

Most newly diagnosed patients with epilepsy do gain lasting control of their seizures, even if their first medication doesn’t work.

Of the roughly 4.6 million Californians between the ages of 16 and 24, more than 10% are considered disconnected, meaning ...

This monumental scientific achievement occurred within a context of intense international collaboration, rapid technical ...

Many things about zero-waste designer Janelle Abbott’s relationship to the fashion industry have changed since she was a kid growing up around her parents' Seattle clothing business.

In vivo preclinicalproof-of-concept data presented at AHA and ESGCT demonstrating >90% LDL-C reduction in non-human primates supports ...

SEP-479 Selected as Next-Generation Oral PTH1R Agonist Development CandidateSEP-631 (MRGPRX2 NAM) Phase 1 Clinical Trial in Healthy Volunteers ...

Chicago-area veterans are increasingly turning to food pantries as VA staffing cuts, SNAP changes and a government shutdown ...

President Donald Trump’s vow to wage the biggest domestic deportation program in American history. Here is a look at the ...

Acurx Pharmaceuticals, Inc. ("Acurx" or the "Company"), a late-stage biopharmaceutical company developing a new class of small molecule antibiotics for difficult-to-treat bacterial infections ...